The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS)
<p>Abstract</p> <p>Polycystic ovary syndrome (PCOS) is a common and complex endocrine disorder affecting 5-10% of women in reproductive age that is characterized by hyperandrogenism, oligo- or anovulation and infertility. However the pathophysiology of PCOS still remains unknown. T...
Saved in:
Main Authors: | Yaba Aylin (Author), Demir Necdet (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2012-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted inhibition of mammalian target of rapamycin (mTOR) enhances radiosensitivity in pancreatic carcinoma cells
by: Dai ZJ, et al.
Published: (2013) -
An emerging role for the mammalian Target of Rapamycin (mTOR) in 'pathological' protein translation: relevance to cocaine addiction
by: Christopher V Dayas, et al.
Published: (2012) -
Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway
by: Yumiko Hori, et al.
Published: (2020) -
Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks
by: Vincenzo Sorrenti, et al.
Published: (2022) -
The Role of Green Tea Catechin Epigallocatechin Gallate (EGCG) and Mammalian Target of Rapamycin (mTOR) Inhibitor PP242 (Torkinib) in the Treatment of Spinal Cord Injury
by: Lucia Machova Urdzikova, et al.
Published: (2023)